Screening for human immunodeficiency virus infection during pregnancy

Pediatric AIDS and HIV Infection

Volumn 8, Issue 1, 1997, Pages 12-14

  Ross, Elaine L ^a   Morrison, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ZIDOVUDINE;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; PATIENT COUNSELING; PERINATAL INFECTION; PREGNANCY; SEROCONVERSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

EID: 0030960675     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Voelker R. Foes of mandatory maternal HIV testing fear guidelines will lead to reprisals. JAMA 1995;273:977-978.
2. Centers for Disease Control. National HIV serosurveillance summary: Results through 1992. Atlanta: US Department of Health and Human Services. Public Health Service, 1994, Vol. 3.
3. Final report, Secretary's Work Group on Pédiatrie HIV Infection and Disease. Washington, DC: US Dept of Health and Human Services, 1988.
4. Hunter ND. Report of the American Civil Liberties Union AIDS project. New York: American Civil Liberties Union, July 1990.
5. Connor EM, Sperling RS, Gelber R, et al. for the Pédiatrie AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994;331: 1173-1180.
6. Mauskopf JA, Paul JE, Wichman DS, et al. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. JAMA 1996;276:132-138.
7. Minkoff H, Willoughby A. Pédiatrie HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys. JAMA 1995;274: 1165-1168.
8. Lindsay MK, Peterson HB, Feng TI, et al. Routine antepartum human immunodeficiency virus infection screening in an innercity population. Obstet Gynecol 1989;74:289-294.
9. Lindsay MK. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening. Am J Obstet Gynecol 1993;168:476-479.
10. Pittman KP. Perinatal HIV transmission reduction. Mississippi Morbidity Report. 1994;13(December):1-4.
11. Horowitz GM, Scott RT, Hankins GD. Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. J Reprod Med 1991;36:773-778.
12. MacDonald MG, Magann EF, Morrison JC. Overview of medical management of HIV-seropositive pregnant women. Ped AIDS HIV Infect: Fetus to Adolesc 1993;4:3-8.
13. HIV transmission route in state AIDS population. The ClarionLedger, Sunday, June 16, 1996.